MENU
IOVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Iovance Biotherapeutics (IOVA) Ownership - Who owns Iovance Biotherapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.38B
P/E Ratio
N/A
Total Cash
397.49M
Projected Growth
N/A
Total Debt
78.94M
Revenue
90.86M
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
0.33 USD as % of share price
Fundamentals
IOVA
Capitalization
2.38B
P/E Ratio
N/A
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash
397M
Total Cash/Share
1.30
Total Debt
78.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.33%
Revenue
90.9M
ROE
N/A
Book Value
773M
P/B Ratio
3.08
Cash Flow
N/A
Earnings
-1.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
4.22
Current Revenue Per Employee
105123.88
Dividends Per Share - Security
N/A
EBITDA
-388.32M
Float
N/A
Float - Current
N/A
Gross Income Margin
31.99
Revenue To Assets
-44.48
Shares Held By Institutions
5.84B
Shares Outstanding - Current
305M
Total Liabilities
218M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-3.936
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biotechnological products for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com